Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Karyotyping01:17

Karyotyping

69.5K
Overview
69.5K
Next-generation Sequencing03:00

Next-generation Sequencing

100.1K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
100.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chromoanagenesis in Myelodysplastic Syndromes Is Associated With Highly Complex Karyotype, TP53 Disruption and Dismal Prognosis.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Long-term follow-up: blinatumomab maintenance after allogeneic hematopoietic cell transplantation for B-lineage acute lymphoblastic leukemia.

Haematologica·2026
Same author

Correction: A mammalian, glutaminase-free asparaginase enhances venetoclax activity in preclinical AML models with chromosome 7 deletion.

Frontiers in oncology·2026
Same author

Unraveling the nexus: Tumor mutational burden, PD-L1 expression, and oncogenic alterations in non-small cell lung cancer cytology specimens.

Cancer cytopathology·2026
Same author

A mammalian, glutaminase-free asparaginase enhances venetoclax activity in preclinical AML models with chromosome 7 deletion.

Frontiers in oncology·2026
Same author

Neurocritical Care Experience and Attitudes Related to Organ Donation in the USA.

Neurocritical care·2026

Related Experiment Video

Updated: Mar 10, 2026

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

10.6K

Comprehensive Cytogenomic Profiling of T-Lymphoblastic Leukemia Using Optical Genome Mapping, Karyotyping, and

Guilin Tang1, Alexandra Reynolds1, Farhad Ravandi-Kashani2

  • 1Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|March 9, 2026
PubMed
Summary
This summary is machine-generated.

Optical genome mapping (OGM) and next-generation sequencing (NGS) significantly improve the detection of genomic alterations in T-lymphoblastic leukemia/lymphoma (T-ALL) compared to karyotyping alone. This comprehensive profiling aids in understanding T-ALL subtypes and risk stratification.

Keywords:
T-cell acute lymphoblastic leukemiacytogenomic profilesnext-generation sequencingoptical genome mapping

More Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.3K
Chromosome Preparation From Cultured Cells
07:42

Chromosome Preparation From Cultured Cells

Published on: January 28, 2014

84.2K

Related Experiment Videos

Last Updated: Mar 10, 2026

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients
13:21

Comprehensive DNA Methylation Analysis Using a Methyl-CpG-binding Domain Capture-based Method in Chronic Lymphocytic Leukemia Patients

Published on: June 16, 2017

10.6K
Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

7.3K
Chromosome Preparation From Cultured Cells
07:42

Chromosome Preparation From Cultured Cells

Published on: January 28, 2014

84.2K

Area of Science:

  • Genomics
  • Oncology
  • Molecular Biology

Background:

  • T-lymphoblastic leukemia/lymphoma (T-ALL) is a heterogeneous lymphoid malignancy.
  • Accurate cytogenomic profiling is crucial for understanding T-ALL biology and guiding treatment.
  • Conventional karyotyping has limitations in detecting all relevant genomic alterations.

Purpose of the Study:

  • To comprehensively analyze cytogenomic alterations in T-ALL using a combination of optical genome mapping (OGM), conventional karyotyping, and next-generation sequencing (NGS).
  • To compare the diagnostic yield of OGM with conventional karyotyping.
  • To identify specific cytogenomic alterations associated with different T-ALL subtypes.

Main Methods:

  • Analysis of 91 T-ALL cases using OGM, karyotyping, and NGS.
  • Detection and characterization of gene rearrangements, copy number variants, and gene mutations.
  • Correlation of cytogenomic findings with T-ALL subtypes.

Main Results:

  • OGM detected cytogenetic abnormalities in 97.8% of T-ALL cases, significantly higher than karyotyping (55%).
  • OGM provided clinically relevant information beyond karyotyping in ~70% of cases.
  • High prevalence of gene mutations (93%), copy number variants (93%), and gene rearrangements (80%) was observed.
  • Specific cytogenomic alterations were associated with early T-precursor (ETP) and cortical T-ALL subtypes.
  • NOTCH1 mutations were the most frequent gene mutations (57%).

Conclusions:

  • Integrated OGM and NGS with karyotyping provide comprehensive cytogenomic profiling for T-ALL.
  • This approach enhances the detection of clinically relevant genomic alterations.
  • Findings may inform T-ALL classification and risk stratification strategies.